Figure 3.
Figure 3. Survival rate of NEMO-deficient patients after HSCT. (A) Survival rate after HSCT, by donor type. MUD, blue dotted line; MSD, red full line; UCB, matched unrelated cord blood donor, green regular small dotted line; haplo-id: haploidentical donor, purple regular large dotted line. (B) Survival rate after HSCT by conditioning regimen. MAC, blue dotted line; RIC, red full line. (C) Survival rate after HSCT, by presence or absence of mycobacterial infection before HSCT. The red full line corresponds to patients with no mycobacterial infection, and the blue dotted line corresponds to patients with mycobacterial infection before HSCT. (D) Survival rate after HSCT, by presence or absence of colitis before HSCT. The red full line corresponds to patients without colitis, and the blue dotted line corresponds to patients with colitis before HSCT.

Survival rate of NEMO-deficient patients after HSCT. (A) Survival rate after HSCT, by donor type. MUD, blue dotted line; MSD, red full line; UCB, matched unrelated cord blood donor, green regular small dotted line; haplo-id: haploidentical donor, purple regular large dotted line. (B) Survival rate after HSCT by conditioning regimen. MAC, blue dotted line; RIC, red full line. (C) Survival rate after HSCT, by presence or absence of mycobacterial infection before HSCT. The red full line corresponds to patients with no mycobacterial infection, and the blue dotted line corresponds to patients with mycobacterial infection before HSCT. (D) Survival rate after HSCT, by presence or absence of colitis before HSCT. The red full line corresponds to patients without colitis, and the blue dotted line corresponds to patients with colitis before HSCT.

Close Modal

or Create an Account

Close Modal
Close Modal